Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis Biotech Investing
Perimeter Medical Imaging AI Reports First Quarter 2021 Financial Results and Provides Corporate Update Medical Device Investing
Hollister Biosciences Inc. Reports Fourth Quarter and Full Year Financial Results Psychedelics Investing
Avricore Health's HealthTab Signs Distribution Agreement to Expand Pharmacy Network and Test Offering Medical Device Investing
ROSEN, A TOP RANKED FIRM, Encourages Braxia Scientific Corp. f/k/a Champignon Brands Inc. Investors to Secure Counsel Before Important June 9 Deadline in Securities Class Action - SHRMF Psychedelics Investing
FDA Approves LUMAKRAS , The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer Biotech Investing
EBON, DOX & SHRMF Looming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm Psychedelics Investing
Titan Medical Receives License Fee of $10 Million Upon Achievement of Milestone Under Medtronic Development Agreement Medical Device Investing
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
